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Abstract 
Background: Lack of knowledge of rational use of antimalarial drugs among medicine vendors is a serious problem, notably in areas of 
intense transmission. These misunderstandings increase the risks of resistance and adverse drug reactions. This study aimed to assess 
knowledge of malaria and environments wherein medicine vendors dispense antimalarials in the Buea community.  
Methods: Administration of a community-based cross-sectional survey of a random sample of 140 medicine vendors living within the Buea 
community occurred between March and June 2017. The survey sought to obtain information from medicine vendors on their general 
knowledge of malaria as well as their dispensing practices. Statistically significant findings were associated with p ≤ .05.  
Results: The majority of participants were aware that use of insecticide – treated bed nets (ITNs) and maintenance of a clean environment 
equate to effective malaria prevention efforts.  Alternatively, only one-third of participants correctly attributed the causative organism of 
malaria to being protozoan. Participants employed within drugstore settings had less knowledge of malaria than their hospital/community 
counterparts did. A directly proportional relationship existed between the amount of experience that participants had in their respective 
disciplines with an increased knowledge of malaria overall.   
Conclusion: These findings reveal fluctuating knowledge of malaria among study participants. Reported antimalarial dispensing practices 
also warrants room for improvement. Routine monitoring and evaluation to prevent emergence of resistant strains to current efficacious 
antimalarials remains paramount. 
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Background 
Malaria remains a leading cause of morbidity and mortality 
worldwide. The global malaria burden is disproportionately high 
in Sub-Saharan Africa, which accounts for 90% of malaria cases 
and 92% of malaria deaths, mostly in children under five years of 
age.1 In Cameroon, over 90% of the population is at risk of malaria 
infection and approximately 41% have at least one episode of the 
disease each year.2 Moreover, malaria accounts for 50–56% of 
morbidity and 40% of the annual mortality in children less than 
five-years old.3 Malaria also imposes a heavy economic burden 
on both individuals and governments, with an estimated direct 
cost of at least US $12 billion per year.1 
 
Significant progress in malaria control has been recorded globally 
that has resulted in a global decrease in malaria incidence and 
death rate by 21% and 29% between 2010 and 2015, respectively, 
in all age groups. An estimated 6.8 million malaria deaths have 
been avoided globally since 2001.1 Nevertheless, the emergence 
and spread of resistance to antimalarial drugs and insecticides,  
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coupled with the lack of a vaccine, have been an impediment to 
the management of malaria especially in endemic regions.1 
Resistance strains have emerged nearly to all available 
antimalarials.1,4  The effectiveness of these antimalarials has 
increasingly waned including examples such as chloroquine (CQ), 
a mainstay of 20th century malaria eradication efforts,4 
sulfadoxine-pyrimethamine (SP), an alternative available for 
large scale implementation for the treatment of uncomplicated 
malaria,1 and atemisinin–based combination therapy (ACT), a 
current first-line treatment for uncomplicated malaria.1 
Resistance is also known to affect all major malaria vector species 
and all four recommended classes of insecticides. Since 2010, a 
total of 60 countries have reported resistance to at least one class 
of insecticide, with a total of 49 of those countries reporting 
resistance to two or more classes.5 
 
This evolution of malaria parasite drug resistance highlights the 
need to identify and constantly monitor strategies that could 
extend the therapeutic use of antimalarial drugs. Additionally, 
there is the need to ascertain and ensure that rational control 
policies, once adopted, are properly implemented. 
 
Current strategies for managing antimalarial resistance focus on 
four key elements which include: preventing the emergence of 
antimalarial drug resistance through rational prescribing and 
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dispensing of antimalarials;4,5 routine monitoring of therapeutic 
efficacy of first-line and second-line ACTs to detect early changes 
in P. falciparum susceptibility to antimalarial drugs in endemic 
countries using in vivo efficacy assays and molecular markers;5 
ensuring a continuous pipeline of new antimalarial medicines 
with a paradigm shift towards complementary and alternative 
medicine (medicinal plants); and containing the spread of 
antimalarial drug resistance once it has emerged.6 Therefore, 
strategies to elicit feedback from citizens residing in areas 
impacted by malaria, along with those directly involved in the 
dispensing of antimalarials seem prudent. Particularly, a 
heightened focus on perceptions of malaria’s etiology, methods 
of acquisition and mechanisms for its prevention, in addition to 
antimalarial prescribing parameters, is apt to inform prevailing 
rationales for rapid spread of resistant strains especially in 
endemic regions.7 
 
Antimalarial drug resistance emerges due primarily to patient 
and health system noncompliance to practices regarding malaria 
treatment policy including irrational prescribing and dispensing 
of antimalarials, misdiagnosis, incorrect dosing, non-adherence 
to antimalarial treatment and poor drug quality.7-10 The above 
phenomena have increasingly been observed among medicine 
vendors. Several studies have reported high proportions of 
presumptive treatment for malaria especially in unauthorized 
medicine vendors.11 These tendencies have the potential to 
facilitate resistance by greatly increasing the number of people 
who are treated unnecessarily but will still be exerting selective 
pressure on the circulating parasite population.11,12 
 
It has further been reported that some medicine vendors lack 
knowledge of prescribing restrictions applied to antimalarial 
medicines.13 This study aimed to assess medicine vendors in the 
Buea health district knowledge of etiology, transmission, clinical 
presentations, and prevention of malaria, in conjunction with 
their understanding of conditions for antimalarial drug 
dispensing in Cameroon. 
 
Methodology 
This study was conducted in the Buea Health District (BHD) in the 
South West Region of Cameroon. BHD has an estimated human 
population of 147,842 inhabitants distributed over 67 
communities.10 Indigenes of the district are of the Bakweri tribe 
and part of the Bantu ethnic group.14 Buea has a Cameroon- type 
equatorial climate characterized by fairly constant temperatures 
ranging from 18°C-29°C with average humidity  
of 80% and two seasons: a short dry season (November–March) 
and a long rainy season (March-November). Malaria transmission 
occurs all year round with two peak periods, the first in April and 
May and the second in October and November.15 The prevalence 
of malaria parasitaemia in the low-altitude areas ranges from 
30% in the dry season to 84% in the rainy season.16 P. falciparum 
is the main species accounting for up to 96% of malaria infections 
in the area while Anopheles gambiae is dominant (most 
aggressive and most active of the three malaria vectors An. 
gambiae, An. funestus and Anopheles nili), accounting for up to 
72.7% of transmission infection rates.17 Entomological 
Inoculation Rate (EIR) to An. gambiae are as high as 287 infective 
bites/ person/year and 3.93 infective bites/person/night.18 The 
study conducted from March to June 2017 was a community- 
based cross-sectional survey of medicine vendors who reportedly 
have been selling medications in the health area for at least two 
years. The sample size was calculated using a standard formula 
for prevalence studies.19 
 
 
Where n = sample size, Zα = standard normal deviate, set at 1.96 
(for 95% CI), p = the estimate of target population who dispense 
medication in the district (10%) and at 95% confidence interval 
and d is a 5% relative precision. A 10% adjustment for non-
responses and invalid responses was added. 
 
Prior to data collection, a semi-structured questionnaire was 
developed and pre-tested for validity. The questionnaire was 
designed to obtain information from medicine vendors on 
knowledge of malaria prevention and acquisition along with 
prescriptive authorities for dispensing antimalarial medications. 
The first part of the questionnaire contained demographics 
including gender, age (in years), professional qualifications, 
dispensary type, and experience (in years). The second part was 
structured to capture information regarding knowledge about 
malaria etiology, transmission, signs and symptoms and 
prevention. For this component of the questionnaire, a “Select All 
that Apply” format was employed. Practices regarding dispensing 
of antimalarial medications were assessed using questions about 
conditions for antimalarials dispensing and knowledge of who is 
qualified to prescribe antimalarial medications. In addition to the 
researcher, two research assistants were recruited and trained to 
administer the structured questionnaire. 
 
The research assistants were trained on the tools to be used, 
purpose of the study and how to approach respondents and obtain 
consent. Data were collected by face-to-face interviews, with 
respondents required to meet the qualification of dispensing 
antimalarial medications for at least two years. Prior to data 
collection, the purpose of the study was carefully explained to 
respondents and written informed consent was obtained before 
questionnaire administration. 
 
Data were double entered in Microsoft Excel and analyzed using 
SPSS Statistics 20.0 (IBM Corp, Atlanta, GA, USA). Descriptive 
statistics were carried out to measure percentages, averages, and 
relative frequencies of the variables. Relationships among the 
dependent variable, knowledge of malaria, and independent 
variables, gender, age group (in years), professional 
qualifications, dispensary type, and experience (in years), were 
assessed using the Pearson’s Chi-Squared (χ2) test at 95% CI. 
Statistical level of significance was set at p ≤ .05. Ethical approval 
was obtained from the Institutional Review Board of Saint Monica 
University (No.2017/SMU/IRB/36). Administrative authorizations 
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were sought from the South West Regional Delegation of  
Public Health and the Buea District Health Service 
(R11/MINSANTE/SWR/RDPH/PS/40/709). Only individuals who 
volunteered to participate by signing a written informed consent, 
after adequate sensitization were enrolled. 
 
Results 
One hundred and forty respondents aged 17 – 50 years old 
participated in the study. Table 1 displays the characteristics of the 
sample. Of note, this cohort contained more than twice as many 
males than females. The predominate age group featured 
participants greater than 20 years but less than 30 years old. 
Professional designations that were in the majority were equally 
split between those with nursing credentials and participants 
without a professional diploma. Respondents that were mostly in 
a drugstore setting, with less than one-half of a decade of 
professional experience, outnumbered study counterparts in 
other dispensary types, and with greater years of experience, in an 
almost two-to-one fashion, respectively. 
 
Table 2 displays knowledge of respondents’ awareness of causes, 
transmission, signs and symptoms, along with prevention 
strategies of malaria. Mosquitoes were implicated in some 
capacity by the majority of respondents as being both causative 
agents and transmission considerations for malaria; the former 
assertion dubbed as inaccurate, as protozoan was the correct 
reply; the latter consideration as partially correct, as the desired 
response was mosquito bite or blood transfusion. Respondents 
were largely familiar with signs and symptoms in isolation that 
may constitute malarial diagnoses such as fever, body weakness, 
vomiting, and headache. However, participants were less likely to 
select at least three signs and symptoms collectively. A similar 
trend existed with knowledge of prevention techniques, with 
more responses garnered for insecticide-treated-bed nets (ITNs) 
and clean environments individually than their synergistic effects. 
 
Table 3 displays participant demographics with correct knowledge 
of malaria based upon domains depicted in Table 2. Two of the 
participant demographics reported to have the highest 
representation in Table 1 (male and age 20-29) demonstrated the 
greatest overall knowledge of malarial principles. However, the 
remaining demographic types, professional qualification, 
dispensary type, and years of experience yielded percentages of 
correct knowledge that did not necessarily mirror the majority 
number of respondents. Specifically, statistically significant 
differences in percentages of correct knowledge occurred within 
both professional qualification and years of experience categories 
(p < .005). 
 
Table 4 displays participant feedback regarding conditions for 
antimalarial drug dispensing. The percentage of respondents 
identified as having a hospital/community pharmacy designation 
conveyed a higher level of understanding of the necessity  
of a prescription for anti-malarial medications by physicians, 
pharmacists, and nurses than drugstore participants. The 
hospital/community pharmacy contingent was also less likely to 
believe that any health worker or any person could perform anti-
malarial dispensing in general. These findings translated into a 
statistically significant difference in good overall dispensing 
practices between the hospital/community pharmacy and 
drugstore sectors (p = .02). 
 
Respondent’s overall knowledge of malaria was deduced from the 
correct responses provided for the various aspects of malaria 
(causative agent, mode of transmission, signs and symptoms and 
methods of prevention) presented on Table 2. A participant with 
correct responses for at least three, two, or one of the aspects was 
considered to have an excellent, fair and poor overall knowledge, 
respectively. Majority [55(39.3%)] of respondents had excellent, 
while 46(32.9%) and 39(27.9%) had fair and poor overall 
knowledge of malaria, respectively. Furthermore, participants 
with excellent and fair knowledge were classified as having an 
appropriate knowledge of malaria overall. In all, 101(72.1%) of 
respondents had a good knowledge of malaria while 39(27.9%) 
had poor knowledge. 
 
Discussion 
Global malaria eradication is threatened on an unprecedented 
scale by rapidly growing resistance of P. falciparum to 
conventional antimalarial drugs. A contributing factor to this 
phenomenon is the misuse of these drugs especially in endemic 
regions. Overuse of these medications coupled with patient 
noncompliance to treatment can lead to misdiagnoses, 
inadequate dosing, incomplete courses and indiscriminate drug 
use as contributing factors to resistance.9,20 This study showed 
that >50% of the drug dispensers in Buea Health District were 
quite knowledgeable about malaria signs and symptoms as well 
as preventive methods (Table 2). These findings are aligned with 
other studies in the district10,21 and other endemic regions such 
as Southeast Iran, Malaysia and South Africa22,23 where 
participants typically have adequate knowledge of the disease 
owing to their frequent exposure to malaria. The study also 
revealed poor knowledge on the cause of malaria with majority 
(62.1%) of respondents attributing the cause of malaria to 
mosquitoes (Table 2). 
 
Only 33.6% knew that a protozoan was the causative agent of 
malaria. It is plausible that respondents may have been unclear 
about the distinction between cause and transmission. 
 
Although the population of participants with accurate knowledge 
about the cause of malaria reported here is relatively high 
compared to studies in Cameroon (31.5%), Ethiopia (1.6%) and 
Tanzania (6%),10,24 the limited knowledge may be attributed to 
the fact that control measures emphasize mosquito related 
problems rather than the parasite. The study also demonstrates 
that the knowledge of malaria was strongly associated with level 
of education. This can be explained by the fact that majority of 
those who have attained at least secondary level of education 
with professional diplomas might have been taught about 
malaria in schools and may also be more likely to read and 
comprehend information on malaria in print media, radio or 
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television. Education clearly influences knowledge about modes 
of malaria transmission, with educated communities having 
access to multiple sources of information when compared with 
their less educated counterparts.21,25,26 Special strategies such as 
community educators are therefore required to reach out to the 
under educated members of the study area with information, 
education and communication messages on malaria control 
measures such as ITN use, care and maintenance of ITN life span 
for protection against malaria.26 
 
With the exception of professional qualification and  
years of experience, correct knowledge of malaria among 
participant demographics was similar (Table 3). As it relates  
to professional qualifications, the category encompassing 
“Pharmacist/MD/Pharmacy Assistant” demonstrated completely 
correct knowledge (100%), being statistically significantly different 
from the other categories (p <.005). 
 
However, with the multiple professional designations housed 
within this category, it is difficult to pinpoint the prevailing 
contributor to these statistically significant findings. The low yield 
of Pharmacist/MD/Pharmacy Assistant participants (n =8) further 
complicates the interpretation of these results in relationship to 
the other groups with almost two to five times greater 
representation, but less knowledge proficiency. There was a 
statistically significantly higher level of knowledge observed in the 
portion of the sample with greater than ten years of experience (p 
< .005). 
 
This increased knowledge base in comparison to peer participants 
appears to be directly proportional to the expertise acquired over 
time in managing various types of malaria presentations. 
 
In general, both medicine vendors in the hospital/community and 
drugstore arenas shared consistent beliefs about conditions for 
antimalarial drug dispensing (Table 4). Some of the uniformity in 
responses may relate to inconsistent viewpoints on phrases such 
as “health worker” or “anybody.” In light of these possible varying 
interpretations, coupled with the dichotomous nature of the 
questions, an ability to confidently confirm or deny appropriate 
antimalarial dispensing conditions may have been challenging. It is 
plausible that the hospital/community dispensing settings 
encountered more patients treated for complex malaria cases 
than the drugstore-dispensing environment. This would 
foreseeably necessitate that the hospital/community group of 
participants remain more in-tuned with clinical developments. 
Therefore, the statistically significant difference in good overall 
dispensing practices may have resulted from disparities in the 
number and nature of encounters with malaria between the two 
groups (p=.02). 
 
There were some noted limitations to our study. Some answer 
choices to questionnaire items populated in a co-formulated 
fashion, e.g., hospital/community pharmacy. These depictions 
limited abilities to confidently associate respondents’ selections 
with their specific intended descriptions. 
Moreover, some respondents may have maintained employment 
in the hospital/community pharmacy and drugstore settings 
concurrently. While this disposition may have been in the 
minority, respondents’ categorizations along these lines may have 
been arbitrary. 
 
Terminology such as “Pharmacy Assistant” may not resonate in 
other pharmacy settings throughout the world. As a result, any 
information inferred about this subset of the study sample may be 
of minimal value globally. Differentiation within the nursing 
continuum, e.g., licensed practical nurse (LPN) or registered nurse 
(RN) did not occur. This lack of specification may not allow the 
respective findings to translate as well to the different members 
of the nursing profession reviewing these results. 
 
Additionally, clarifying dialogues that ostensibly resulted between 
the research assistants and the study participants could have 
confounded the findings. 
 
As the research assistants received training on how to approach 
respondents, questions directed towards them may have led to 
certain respondents receiving insights unavailable to others. 
Nonetheless, this research study overall provided vital information 
about perceptions of medicine vendors’ mindsets towards malaria 
acquisition, prevention, and antimalarial prescribing constraints. 
The results generated here are prone to assist public health 
initiatives continue to address accounts of morbidity and mortality 
attributed to malaria worldwide. 
 
Conclusion 
Efforts to elevate awareness about malaria prevention, 
acquisition, and containment remain in high demand. 
Effectiveness of antimalarial medications are prone to abate if 
resistance continues to mount. Customizable community 
messages to target audiences that inspire a sense of responsibility 
to become and remain informed about malaria control procedures 
are paramount. The findings reported here indicate that sustained 
global progress in this regard is well within reach. 
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Table 1 
Demographics of respondents (N = 140) 
 
Demographics  Number (n) Percent (%) 
Gender Male 95 67.9 
 Female 45 32.1 
 
Age Group 
(years) 
<20 6 4.3 
20-29 64 45.7 
 30-39 56 40 
 40-49 14 10 
 
Professional 
Qualification 
Pharmacist/MD/Pharmacy Assistant† 8 5.7 
Nurse 55 39.3 
 Other Degrees 22 15.7 
 No Professional Diploma 55 39.3 
Dispensary 
Type 
Hospital/Community Pharmacy‡ 59 42.1 
Drugstore 81 57.9 
 
Experience 
(years) 
<5 87 62.1 
6-10 30 21.4 
 >10 23 16.4 
†Pharmacist Assistant: Individual that contributes to the overall medication dispensing process in the presence or 
absence of formalized educational training. 
†MD: Medical Doctor 
‡Hospital Pharmacy: A pharmacy location that dispenses traditional medications within an inpatient setting. 
‡Community Pharmacy: A pharmacy location that dispenses traditional medications within a residential clinic 
facility. 
‡Drugstore: A medicinal market that encompasses sell of traditional and nontraditional medications and holistic 
remedies. 
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Table 2 
Respondents’ knowledge of malaria cause, transmission, signs/symptom and prevention (N=140) † 
 
Knowledge Factors Frequency % Frequency 
 Virus 7 5 
 Protozoan 47 33.6 
 Bacteria 9 6.4 
Causative agent Mosquito 87 62.1 
  
Mosquito bite 
 
135 
 
96.4 
 Dirty water 18 12.9 
 Contact with patient 4 29 
 Blood transfusion 8 5.7 
 
Transmission 
Mosquito bite or blood 
transfusion 
 
143 
 
>100% 
  
Fever 
 
120 
 
85.7 
 Body weakness 96 68.6 
 Constipation 12 8.6 
 Vomiting 66 47.1 
 Headache (HA) 94 67.1 
 Stomach disorder 12 8.6 
 
Signs and 
symptoms 
At least three of the 
following: fever, body 
weakness, vomiting, HA 
 
 
77 
 
 
55 
  
Use of ITNs 
 
112 
 
80 
 Avoid dirty water 10 7.1 
 Clean environment 110 78.6 
 Safe sexual intercourse 41 29.3 
Prevention ‡ITNs &clean environment 88 62.9 
 
†Some respondents selected more than one answer. Number of responses exceeded 140-participant total. Bolded answers: 
Correct responses 
‡ITNs: Insecticide – treated bed nets 
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Table 3 
Demographic factors of participants with correct knowledge of malaria 
 
  Correct Knowledge 
[n(%)] 
Level of Significance 
 Demographics Chi-Square P-Value 
 Male 68 (71.6) .47 .83 
Gender Female 33 (73.3)   
  
<20 
 
4(66.7) 
 
.79 
 
.84 
 20-29 48(75) 
 30-39 40(71.4)   
Age group 40-49 9(64.3)   
  
Pharmacist/MD/Pharmacy Assistant† 
 
8(100) 
 
14.69 
 
<.005 
 Nurse 42(76.4) 
Professional 
Qualification 
Other Degrees 14(63.6)   
No Professional Diploma 32(58.2)   
 
Dispensary 
Type 
 
Hospital/community Pharmacy‡ 
 
47(79.7) 
 
2.87 
 
.09 
Drugstore 54(66.7)   
  
<5 
 
47 (54) 
 
11.19 
 
<.005 
Experience 
(years) 
5-10 11 (36.7)   
>10 19 (82.6)   
†Pharmacist Assistant: Individual that contributes to the overall medication dispensing process in the presence or 
absence of formalized educational training. 
†MD: Medical Doctor 
‡Hospital Pharmacy: A pharmacy location that dispenses traditional medications within an inpatient setting. 
‡Community Pharmacy: A pharmacy location that dispenses traditional medications within a residential clinic facility. 
‡Drugstore: A medicinal market that encompasses sell of traditional and nontraditional medications and holistic remedies. 
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Table 4 
Conditions for antimalarial drug dispensing (N = 139) † 
 
Conditions for dispensing 
antimalarials 
Response Dispensing Type n (%) Level of Significance 
 Hospital/community 
N=58 
Drugstore 
N=81 
Chi-square P-value 
 
Prescription by 
physician/pharmacist/nurse 
 
Yes 
 
46(79.3) 
 
62(76.5) 
  
No 12(20.7) 19(23.5) .149 .70 
Prescription by any health 
worker 
Yes 17(29.3) 27(33.3)   
No 41(70.7) 54(66.7) .253 .61 
Prescription by anybody‡ Yes 1(1.7) 9(11.1) 
  
 No 57(98.3) 72(88.9) 4.461 .06 
Overall dispensing 
practices 
*1Good 30(51.7) 26(32.1) 
  
*2Poor 28(48.3) 55(67.9) 5.411 .02 
 
†One hospital/community pharmacy respondent did not complete this portion of the survey (139/140) 
‡Anybody: Any individual, including but not limited to physician, pharmacist, nurse, or any other individual 
*1 If conditions for dispensing are exclusively from prescription by physician/nurse/pharmacist 
*2 Conditions for dispensing include prescription from any of the following: anybody, any health worker 
 
 
 
 
